Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1528-3658

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome ; volume:26 ; number:1 ; day:30 ; month:12 ; year:2020 ; pages:1-2 ; date:12.2020
Molecular medicine ; 26, Heft 1 (30.12.2020), 1-2, 12.2020

Creator: Palmblad, Karin
Schierbeck, Hanna
Sundberg, Erik
Horne, Anna-Carin
Harris, Helena Erlandsson
Henter, Jan-Inge
Antoine, Daniel J.
Andersson, Ulf

Contributor: SpringerLink (Online service)

DOI: 10.1186/s10020-020-00263-2

URN: urn:nbn:de:101:1-2021020218015707739570

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Palmblad, Karin
Schierbeck, Hanna
Sundberg, Erik
Horne, Anna-Carin
Harris, Helena Erlandsson
Henter, Jan-Inge
Antoine, Daniel J.
Andersson, Ulf
SpringerLink (Online service)

Other Objects (12)

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis

Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

Related objects

Reset password